This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Presence of Receptors and Inhibition of Growth In Vitro

Amanda M. Saulenas; Steven M. Cohen; L. Lyndon Key, MD; Cynthia Winter; Daniel M. Albert, MD

Arch Ophthalmol. 1988;106(4):533-535.

Abstract
• The vitamin D receptor has been found in several human organs not involved in calcium metabolism and in several malignant neoplasms found in humans. The role of the receptor in these tissues is unclear. There is, however, a relationship between the presence and quantity of the vitamin D receptor in a malignant cell line and the antineoplastic effect of vitamin D on that cell line. We found that Y-79 retinoblastoma cells have receptors specific for calcitriol (1,25-dihydroxycholecalciferol). Scatchard analysis of the receptor data shows a quantity of 56 000 receptors per retinoblastoma cell. These receptors have a dissociation constant of 1.18 nmol/L. Retinoblastoma cells treated with 10–⁹ mol/L of calcitriol for nine days had 15% less cell growth than the control cells. Further studies of the effect of vitamin D on retinoblastoma may warrant its inclusion in chemotherapeutic protocols for the treatment of this childhood affliction.

Author Affiliations
From the Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston.

Footnotes
Accepted for publication Dec 29, 1987.

Reprint requests to Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 24 Charles St, Boston, MA 02114 (Dr Albert).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association between a Protein Polymorphism in the Start Codon of the Vitamin D Receptor Gene and Severe Diabetic Retinopathy in C-Peptide-Negative Type 1 Diabetes
Taverna et al.
J. Clin. Endocrinol. Metab. 2005;90:4803-4808.
ABSTRACT | FULL TEXT  

Effectiveness of Vitamin D Analogues in Treating Large Tumors and During Prolonged Use in Murine Retinoblastoma Models
Albert et al.
Arch Ophthalmol 2004;122:1357-1362.
ABSTRACT | FULL TEXT  

Effectiveness of 1{alpha}-Hydroxyvitamin D2 in Inhibiting Tumor Growth in a Murine Transgenic Pigmented Ocular Tumor Model
Albert et al.
Arch Ophthalmol 2004;122:1365-1369.
ABSTRACT | FULL TEXT  

Vitamin D Analogues Increase p53, p21, and Apoptosis in a Xenograft Model of Human Retinoblastoma
Audo et al.
IOVS 2003;44:4192-4199.
ABSTRACT | FULL TEXT  

Toxicity and Dose-Response Studies of 1{alpha}-Hydroxyvitamin D2 in a Retinoblastoma Xenograft Model
Grostern et al.
Arch Ophthalmol 2002;120:607-612.
ABSTRACT | FULL TEXT  

Antineoplastic Effect and Toxicity of 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 in Athymic Mice With Y-79 Human Retinoblastoma Tumors
Sabet et al.
Arch Ophthalmol 1999;117:365-370.
ABSTRACT | FULL TEXT  

Antineoplastic Effect of 1,25-Dihydroxy-16-ene-23-yne-Vitamin D3 Analogue in Transgenic Mice With Retinoblastoma
Shternfeld et al.
Arch Ophthalmol 1996;114:1396-1401.
ABSTRACT